Trust Co. of Vermont Invests $4.23 Million in Cigna Group $CI

Trust Co. of Vermont acquired a new stake in Cigna Group (NYSE:CI) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 15,346 shares of the health services provider’s stock, valued at approximately $4,231,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Wilkerson Advisory Group LLC acquired a new stake in Cigna Group in the fourth quarter valued at approximately $25,000. Kemnay Advisory Services Inc. acquired a new position in Cigna Group during the 4th quarter worth approximately $29,000. Prosperity Bancshares Inc acquired a new position in Cigna Group during the 4th quarter worth approximately $29,000. Cedar Mountain Advisors LLC increased its position in shares of Cigna Group by 161.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 68 shares during the last quarter. Finally, ANTIPODES PARTNERS Ltd acquired a new stake in shares of Cigna Group in the 2nd quarter valued at $34,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Wolfe Research reaffirmed an “outperform” rating and set a $315.00 price objective on shares of Cigna Group in a research report on Tuesday, June 16th. Jefferies Financial Group lowered Cigna Group from a “buy” rating to a “hold” rating and dropped their target price for the company from $336.00 to $307.00 in a report on Tuesday, August 4th. Guggenheim raised their price target on Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Mizuho lifted their price target on Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Finally, Robert W. Baird set a $362.00 price objective on Cigna Group in a research report on Friday, July 31st. Fifteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $339.45.

Insider Activity

In other news, insider Nicole S. Jones sold 19,436 shares of Cigna Group stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the sale, the insider owned 27,256 shares in the company, valued at approximately $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.60% of the company’s stock.

Cigna Group Stock Down 2.7%

Shares of NYSE:CI opened at $275.03 on Tuesday. The firm has a 50 day simple moving average of $285.73 and a 200-day simple moving average of $281.32. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $72.67 billion, a PE ratio of 11.38, a P/E/G ratio of 0.97 and a beta of 0.29.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same period last year, the firm posted $7.20 EPS. The company’s revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities analysts predict that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. Cigna Group’s dividend payout ratio (DPR) is presently 25.82%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.